Working women spend $15.4 billion more than men in out-of-pocket health costs, study finds

Working women spend .4 billion more than men in out-of-pocket health costs, study finds


Luis Alvarez | Digitalvision | Getty Images

High health care costs are hitting women in the U.S. workforce much harder than men.

Working women spend $15.4 billion more in out-of-pocket health expenses annually compared to their male counterparts, according to a new analysis of employer-sponsored health plans from Deloitte Consulting.

The study found women spend 18% more than men on co-pays and deductibles, on average. That’s after excluding costs associated with pregnancy and maternity, according to the new report, and despite total health expenditures for women that are just 10% higher than for men.

“This is a problem we’re identifying that business leaders can actually solve within their own organizations. The takeaway being that women get paid less, and that they pay more for health care,” said Dr. Kulleni Gebreyes, U.S. chief health equity officer at Deloitte Consulting.

The result, she said, is a disproportionate financial burden.

Women tend to utilize more medical care than men, in part due to annual gynecological exams and the high costs of breast cancer imaging.

While annual exams are often fully covered, follow-ups that can result from those visits incur co-pays and trigger deductibles. Many of those services are often more expensive than the typical deductible, leading to a higher cost-sharing burden.    

The Deloitte analysts say employers could close the $15.4 billion cost-sharing gender gap through enhanced benefits design, at an estimated cost of $133 per employee per year, or about $11 per month.

“Our ask is that companies look at their data; examine if and where the gaps exist and step back to have more of an equitable design process to come up with what are the health benefits that would meet the needs of their workforce,” said Gebreyes.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More